NCT02283801View on ClinicalTrials.gov

Open-label Drug Interaction Study Between Eslicarbazepine Acetate and Lamotrigine.

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions
Epilepsy
Interventions
DRUG

Eslicarbazepine acetate

DRUG

Lamotrigine

All Listed Sponsors
lead

Bial - Portela C S.A.

INDUSTRY

NCT02283801 - Open-label Drug Interaction Study Between Eslicarbazepine Acetate and Lamotrigine. | Biotech Hunter | Biotech Hunter